logo-loader

Allergy Therapeutics PLC

Receive alerts
Market:
AIM
Market Cap:
£67.43 m
Price
10.60 GBX
Change
0.00%
52 weeks high
16.60
52 weeks low
8.00

In brief

We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.

Deep dive We explore the investor case for growth companies

Snapshot

  • Profitable allergy specialist developing new inoculations
  • Full-year results exceeded expectations
  • Strong pipeline of new products under development